Research Study

A Double-Blind, Placebo-Controlled Randomized, Multicenter Study to Assess Changes in Omega-3 Index in Erythrocytes and Health Benefit After 24 Weeks of Daily Consumption of AKBM-3031 (Omega-3 Phospholipids From Krill), Followed by a 24 Week Open-Label Extension, in Patients With Systemic Lupus Erythematosus (SLE)
Principal Investigator 
Juan Antonio Aviña-Zubieta

Overview

Body Locations and Systems 
Lupus
ClinicalTrials.gov# 
NCT03626311
Status 
Recruiting
Study Start/End 
Mar 12, 2019 to Jun 30, 2020
Locations 
Mary Pack Arthritis Centre
Name/Title 
Liliana Cartagena Tapia, Research Coordinator
Phone 
604-875-4111 ext.63323
Purpose of Study 

The purpose of this study is to investigate whether treatment with AKBM-3031 is able to replenish the omega-3 deficiency in patients with Systemic Lupus Erythematosus (SLE), as well as investigating further positive effects with regards to altering immune function and improving general health. 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.